Enhanced Apoptosis and Tumor Growth Suppression Elicited by Combination of MEK (Selumetinib) and mTOR Kinase Inhibitors (AZD8055)Sarah V. Holt, Paul D. Smith, Armelle Logié et al.|Cancer Research|2012Cited by 86
Frequency, characterization, and prognostic analysis of PIK3CA gene mutations in Chinese esophageal squamous cell carcinomaJun Hou, Lijie Tan, Yingyong Hou et al.|Human Pathology|2013Cited by 28
Supplementary Methods from Enhanced Apoptosis and Tumor Growth Suppression Elicited by Combination of MEK (Selumetinib) and mTOR Kinase Inhibitors (AZD8055)Sarah V. Holt, Paul D. Smith, Armelle Logié et al.|Unknown|2023Cited by 0
Supplementary Methods from Enhanced Apoptosis and Tumor Growth Suppression Elicited by Combination of MEK (Selumetinib) and mTOR Kinase Inhibitors (AZD8055)Sarah V. Holt, Paul D. Smith, Armelle Logié et al.|Unknown|2023Cited by 0
Data from Enhanced Apoptosis and Tumor Growth Suppression Elicited by Combination of MEK (Selumetinib) and mTOR Kinase Inhibitors (AZD8055)Sarah V. Holt, Paul D. Smith, Armelle Logié et al.|Unknown|2023Cited by 0